Betta Pharmaceuticals' subsidiary Xcovery has reached a commercialization partnership agreement with the American company Eversana for the drug Ensafernib.

Recently, Bada Pharmaceutical Holdings' subsidiary Xcovery Holdings, Inc. partnered with global commercialization services provider Eversana to jointly promote the commercial expansion of Ensacove in the US market.